Goldman Sachs Group Inc

Filing Details

13F-HR/A • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
CIK
0000886982
Manager Name
Goldman Sachs Group Inc
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions
Manager:
SEC
Search and click to pin securities to the top
Page 252 of 253
G63369113
G63369113
Shares:
22905(+0.0%)
Value:
$5.3M(+4.5%)
Brand Engagement Network Inc.
BNAIW|104932116
Shares:
273919(+0.0%)
Value:
$5.2M(-66.0%)
M6000J127
M6000J127
Shares:
461458(+0.0%)
Value:
$5.1M(-70.4%)
Abpro Holdings, Inc.
ABPWW|000847111
Shares:
179100(+0.0%)
Value:
$4.6M(-59.2%)
G8675V127
G8675V127
Shares:
17930(+0.0%)
Value:
$4.5M(-40.9%)
29415V117
29415V117
Shares:
125039(+0.0%)
Value:
$4.1M(-29.3%)
Passage BIO, Inc.
PASG|702712100
Shares:
11596(-57.1%)
Value:
$4.1M(-73.3%)
Co-Diagnostics, Inc.
CODX|189763105
Shares:
13006(-18.7%)
Value:
$4.0M(-66.4%)
G85727116
G85727116
Shares:
21194(+0.0%)
Value:
$4.0M(-40.6%)
Above Food Ingredients Inc.
ABVEW|00373V118
Shares:
168645(+0.0%)
Value:
$3.7M(-18.1%)
Cellectar Biosciences, Inc.
CLRB|15117F807
Shares:
10807(-74.5%)
Value:
$3.4M(-73.2%)
74449F118
74449F118
Shares:
200117(+0.0%)
Value:
$3.4M(+17.3%)
Ernexa Therapeutics Inc.
ERNA|114082209
Shares:
18050(+40.9%)
Value:
$3.2M(-14.7%)
Adaptimmune Therapeutics PLC
ADAP|00653A107
Shares:
16149(-0.1%)
Value:
$3.2M(-63.5%)
37961B112
37961B112
Shares:
34800(+0.0%)
Value:
$3.0M(-19.6%)
Aeva Technologies, Inc.
AEVAW|00835Q111
Shares:
35165(+0.0%)
Value:
$2.8M(+23.8%)
Beneficient
BENFW|08178Q119
Shares:
379725(+0.0%)
Value:
$2.8M(-5.2%)
M7S64L107
M7S64L107
Shares:
19008(+0.0%)
Value:
$2.6M(+123.1%)
N2OFF, Inc.
NITO|80512Q402
Shares:
10598
Value:
$2.5M
VEEA INC.
VEEAW|693489114
Shares:
32268(+0.0%)
Value:
$2.4M(-53.1%)